Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

Crispr Therapeutics Ag (NASDAQ:CRSP) is one of the Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. Biotech company Crispr ...

WAM - Scientists at the University of California have developed a new method to treat blood cancers by reprogramming immune cells directly inside the patient’s body, rather than extracting and ...

Stanford Medicine researchers have built CRISPR-GPT, a large language model designed to automate the full arc of gene-editing ...

We will know even more about the company's prospects in a year as it releases clinical data for various pipeline candidates.

A Dallas-based biotech company called Colossal Biosciences says it has produced “de-extinct” dire wolf pups using gene-editing technology, but critics argue the animals are genetically modified gray ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Genomics (NasdaqGS:TXG) is collaborating with PerturbAI, NVIDIA, and the Allen Institute on what is described as the largest in vivo CRISPR brain atlas. The partnership combines 10x Genomics' single ...

PerturbAI, an AI-native therapeutics company accelerating drug discovery through systems-level understanding of diseases, emerged from stealth today with the public release of the world's largest in ...

The first-in-human Phase-I clinical trial for gene therapy of Hemophilia A has shown clinically significant outcomes.

A biotech company says CRISPR could revive extinct animals like the dodo and mammoth — but many scientists remain skeptical.

A Dallas-based startup says it has produced three “de-extinct” dire wolf pups using gene-editing technology — and the dodo and woolly mammoth are next. But the gap between the company’s marketing and ...